Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
International Journal of Molecular Sciences|August 6, 2014
Cystic fibrosis related liver disease--another black box in hepatologyKatharina Staufer, Emina Halilbasic, Michael Trauner, et al.Clinical and Experimental Rheumatology|September 3, 2016
Bile acids in regulation of inflammation and immunity: friend or foe?Ci Zhu, Claudia D Fuchs, Emina Halilbasic, et al.Digestive Diseases (Basel, Switzerland)|December 8, 2015
Therapy of Primary Sclerosing Cholangitis--Today and TomorrowEmina Halilbasic, Claudia Fuchs, Harald Hofer, et al.Journal of Hepatology|May 8, 2020
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adultsAlbert Friedrich Stättermayer, Emina Halilbasic, Fritz Wrba, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2014
The role of canalicular ABC transporters in cholestasisFrans J C Cuperus, Thierry Claudel, Julien Gautherot, et al.Digestive Diseases (Basel, Switzerland)|June 22, 2011
Targeting nuclear bile acid receptors for liver diseaseMichael Trauner, Anna Baghdasaryan, Thierry Claudel, et al.International Journal of Molecular Sciences|October 27, 2022
A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy WomenFinn Jung, Raphaela Staltner, Anja Baumann, et al.Digestive Diseases (Basel, Switzerland)|July 19, 2014
Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathiesMichael Trauner, Emina Halilbasic, Lili Kazemi-Shirazi, et al.Journal of Magnetic Resonance Imaging : JMRI|June 6, 2020
In Vivo 1 H MR Spectroscopy of Biliary Components of Human Gallbladder at 7TMartin Gajdošík, Marek Chmelík, Emina Halilbasic, et al.European Journal of Nutrition|July 20, 2022
Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCsFinn Jung, Raphaela Staltner, Ammar Tahir, et al.Pageof 8